# Lidocaine Hydrochloride and Dextrose

NDC: 0338-0409
Generic name: Lidocaine Hydrochloride
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 19810422

FDA application: NDA018461

## Active ingredients

- LIDOCAINE HYDROCHLORIDE: 4 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-0409"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-0409
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f21512ea-c7c3-4766-b976-b2c0b5616bf0